Pfizer and BioNTech shares rise after FDA grants 2 coronavirus vaccines \'fast track\' status (PFE\, BNTX)

Pfizer and BioNTech shares rise after FDA grants 2 coronavirus vaccines 'fast track' status (PFE, BNTX)

Business Insider Monday, 13 July 2020 ()
Pfizer and BioNTech shares rise after FDA grants 2 coronavirus vaccines 'fast track' status (PFE, BNTX)**

· *Two experimental coronavirus vaccines developed by Pfizer and BioNTech received Fast Track status from the US Food and Drug Administration, the companies announced Monday.*
· *Pfizer shares gained nearly 3% in premarket trading Monday. *
· *BioNTech's US shares surged as much as 11% in premarket trading...
0
shares
 
Video credit: Reuters - Politics - Published
News video: Pfizer, BioNTech get vaccine 'fast track' from FDA

Pfizer, BioNTech get vaccine 'fast track' from FDA 01:02

 Pfizer Inc and partner BioNTech SE said on Monday two of their experimental coronavirus vaccines received 'fast track' designation from the U.S. Food and Drug Administration, speeding up the regulatory review process. Jillian Kitchener has more.